The high burden of inpatient diabetes mellitus: The melbourne public hospitals diabetes inpatient audit

Medical Journal of Australia

Volumn 201, Issue 6, 2014, Pages 334-338

  Bach, Leon A ^a,b   Ekinci, Elif I ^c,d   Engler, Dennis ^b,e   Gilfillan, Chris ^b,f   Hamblin, P Shane ^a,d,g   MacIsaac, Richard J ^d,h   Soldatos, Georgia ^b,e   Steele, Cheryl ^g   Ward, Glenn M ^d,h   Wyatt, Sue ^a  

^a Alfred Health ^*  (Australia)

^b MONASH UNIVERSITY   (Australia)

^c AUSTIN HEALTH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e SOUTHERN HEALTH   (Australia)

^f EASTERN HEALTH   (Australia)

^g WESTERN HEALTH   (Australia)

^h ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE; GLUCOCORTICOID; METFORMIN; SULFONYLUREA;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CARDIOVASCULAR MALFORMATION; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE SURVEY; HOSPITAL PATIENT; HUMAN; INTERVIEW; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; PREVALENCE; PSYCHIATRY; RESEARCH; TERTIARY CARE CENTER; UROGENITAL TRACT INFECTION; AGED; AUSTRALIA; COST OF ILLNESS; HOSPITALIZATION; MULTICENTER STUDY; PUBLIC HOSPITAL; STATISTICS;

ADULT; AGED; COST OF ILLNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HOSPITALIZATION; HOSPITALS, PUBLIC; HUMANS; MIDDLE AGED; PREVALENCE; VICTORIA;

EID: 84910017396     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.00104     Document Type: Article

References (22)

1. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
2. Australian Institute of Health and Welfare. Diabetes prevalence in Australia: an assessment of national data sources. Canberra: AIHW, 2009. (AIHW Cat. No. CVD 46.) http://www.aihw.gov.au/publicationdetail/? id=6442468288 (accessed Jun 2014).
3. National Diabetes Services Scheme. All types of diabetes. Statistical snapshot. 2013 http:// www.ndss.com.au/Global/Data Snapshots/ December 2013/NDSS-StatisticalSnapshot- 31December-v1401_AllTypes.pdf (accessed Jun 2014).
4. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care 2013; 36: 1033-1046.
5. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of inhospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-982.
6. National Health Service. National Diabetes Inpatient Audit (NaDIA) – 2011. Key fi ndings about the quality of care of inpatients with diabetes in England and Wales. Leeds, UK: Heath and Social Care Information Centre, 2012. http://www.hscic.gov.uk/catalogue/ PUB06279/nati-diab-inp-audi-11-nat-rep.pdf (accessed Jun 2014).
7. Kubo T, Fujino Y, Murata A, et al. Prevalence of type 2 diabetes among acute inpatients and its impact on length of hospital stay in Japan. Intern Med 2011; 50: 405-411.
8. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium: IDF, 2013. http://www.idf.org/diabetesatlas (accessed Jun 2014).
9. National Diabetes Services Scheme. Australian Diabetes Map 2013. http://www.ndss.com.au/ en/Australian-Diabetes-Map/Map (accessed Oct 2013).
10. Australian Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2011. (ABS Cat. No. 2033.0.55.001.) http://www.abs.gov. au/ausstats/abs@.nsf/DetailsPage/2033.0.55. 0012011?OpenDocument (accessed Sep 2013).
11. Australian Bureau of Statistics. Australian Health Survey: Updated Results, 2011-2012. Canberra: ABS, 2013. (ABS Cat. No. 4364.0.55.003.) http://www.abs.gov.au/ ausstats/abs@.nsf/Lookup/1A8F3DE217DE 1057 CA257B82001792F4?opendocument (accessed Sep 2013).
12. Australian Bureau of Statistics. National Regional Profi le 2007-2011. Canberra: ABS, 2013. http://www.ausstats.abs.gov.au/ ausstats/nrpmaps.nsf/NEW+GmapPages/ national+regional+profi le (accessed Sep 2013).
13. Zgibor JC, Songer TJ, Kelsey SF, et al. Infl uence of health care providers on the development of diabetes complications: long-term follow-up from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2002; 25: 1584-1590.
14. Jackson C, Tsai J, Brown C, et al. GPs with special interests - impacting on complex diabetes care. Aust Fam Physician 2010; 39: 972-974.
15. Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care 2004; 27 Suppl 1: S79-S83.
16. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
17. Collins R, Armitage J, Parish S, et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005-2016.
18. Australian Institute of Health and Welfare. Health service use 2013. http://www. aihw.gov.au/diabetes/health-serviceuse/# hospitalisations (accessed Mar 2014).
19. Australian Institute of Health and Welfare. Australian hospital statistics 2011-12. Canberra: AIHW, 2013. (AIHW Cat. No. HSW 134; Health Services Series 50.) http://www.aihw.gov.au/ publication-detail/?id=60129543133 (accessed Jun 2014).
20. Whitston M, Chung S, Henderson J, Young B. What can be learned about the impact of diabetes on hospital admissions from routinely recorded data? Diabet Med 2012; 29: 1199-1205.
21. Baker ST, Chiang CY, Zajac JD, et al. Outcomes for general medical inpatients with diabetes mellitus and new hyperglycaemia. Med J Aust 2008; 188: 340-343.
22. American Diabetes Association. Standards of medical care in diabetes -- 2013. Diabetes Care 2013; 36 Suppl 1: S11-S6 6.s